Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties (Q41593035)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 May 2017
edit
Language Label Description Also known as
English
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties
scientific article published on 23 May 2017

    Statements

    Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties (English)
    0 references
    0 references
    0 references
    Federica Costa
    Rosanna Vescovini
    Marina Bolzoni
    Valentina Marchica
    Denise Toscani
    Fabrizio Accardi
    Laura Notarfranchi
    Benedetta Dalla Palma
    Cristina Manferdini
    Giannalisa Todaro
    Gina Lisignoli
    Franco Aversa
    Nicola Giuliani
    23 May 2017
    53053-53067

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit